Opus Genetics (IRD) Shares Outstanding (2010 - 2026)

Opus Genetics (IRD) has reported Shares Outstanding (Entity) for 17 consecutive years, with $71.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 110.72% year-over-year to $71.4 million; the TTM figure through Mar 2026 stood at $71.4 million (up 110.72% YoY), while the FY2025 annual figure was $69.9 million, up 121.36% from the prior year.
• Shares Outstanding (Entity) climbed to $71.4 million in Q1 2026 per IRD's latest filing, from $69.9 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $71.4 million in Q1 2026 and bottomed at $19.2 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $34.0 million across 5 years, with a median of $25.1 million in 2024.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) advanced 4.41% — and 2025, when it jumped 146.37%.
• Opus Genetics' Shares Outstanding (Entity) stood at $20.9 million in 2022, then rose by 14.94% to $24.0 million in 2023, then surged by 31.68% to $31.6 million in 2024, then surged by 121.36% to $69.9 million in 2025, then increased by 2.16% to $71.4 million in 2026.
• Business Quant data shows IRD's Shares Outstanding (Entity) at $71.4 million in Q1 2026, $69.9 million in Q4 2025, and $64.5 million in Q3 2025.